Literature DB >> 7323495

Acute mountain sickness and the edemas of high altitude: a common pathogenesis?

P H Hackett, D Rennie, R F Grover, J T Reeves.   

Abstract

Within days of ascent to high altitude when symptoms of acute mountain sickness (AMS) are common, pulmonary and cerebral edema may also develop. Although peripheral edema of the hands, face or feet may also appear, its association with AMS is unclear. In addition, persons with high altitude pulmonary edema often report an antidiuresis. Hence, altitude sickness appears to result from abnormalities in the handling of body water. To test this hypothesis, we studied 102 men and women who were trekking in the Mount Everest region of Nepal. Most were seen both at low (1377 m) and at high (4243 m) altitude. Severity of AMS was measured by an established Symptom Score derived from a questionnaire and physical examination. Change in body water was inferred from change in body weight in less than 10 days. Peripheral edema was assessed separately by physical examination. AMS Symptom Score correlated directly with weight change; those who remained well lost weight, whereas increasing signs and symptoms of AMS occurred in those with increasing weight gain. The symptomatic subjects also developed peripheral edema and reported decreased urinary output. These findings support the hypothesis that with rapid ascent to high altitude, abnormalities in the handling of body water, with antidiuresis, result in fluid retention (weight gain) manifest as peripheral, pulmonary, and/or cerebral edema.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7323495     DOI: 10.1016/0034-5687(81)90133-x

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  8 in total

1.  Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial.

Authors:  H R Keller; M Maggiorini; P Bärtsch; O Oelz
Journal:  BMJ       Date:  1995-05-13

Review 2.  High altitude pulmonary oedema: still a place for controversy?

Authors:  J P Richalet
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

3.  Acetazolamide and dexamethasone in the prevention of acute mountain sickness.

Authors:  S C Zell; P H Goodman
Journal:  West J Med       Date:  1988-05

Review 4.  Airline chair-rest deconditioning: induction of immobilisation thromboemboli?

Authors:  John E Greenleaf; Nancy J Rehrer; Stanley R Mohler; David T Quach; David G Evans
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

5.  High-altitude pulmonary edema in Vail, Colorado, 1975-1982.

Authors:  A M Sophocles
Journal:  West J Med       Date:  1986-05

6.  Total Body Water Dynamics Estimated with Bioelectrical Impedance Vector Analysis and B-Type Natriuretic Peptide After Exposure to Hypobaric Hypoxia: A Field Study.

Authors:  Giacomo Strapazzon; Matiram Pun; Tomas Dal Cappello; Emily Procter; Piergiorgio Lochner; Hermann Brugger; Antonio Piccoli
Journal:  High Alt Med Biol       Date:  2017-10-16       Impact factor: 1.981

7.  Bioelectrical Impedance Vector Analysis: A Valuable Tool to Monitor Daily Body Hydration Dynamics at Altitude.

Authors:  Ivo B Regli; Rachel Turner; Simon Woyke; Simon Rauch; Hermann Brugger; Hannes Gatterer
Journal:  Int J Environ Res Public Health       Date:  2021-05-20       Impact factor: 3.390

8.  Physiological variables associated with the development of acute mountain sickness at the South Pole.

Authors:  Michael F Harrison; Paul Anderson; Andrew Miller; Kathy O'Malley; Maile Richert; Jacob Johnson; Bruce D Johnson
Journal:  BMJ Open       Date:  2013-07-17       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.